Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity

Hypertension

Volumn 52, Issue 4, 2008, Pages 687-695

  Agapitov, Alexei Vasilievich ^a   Correia, Marcelo Lima De Gusmão ^a,b   Sinkey, Christine Ann ^a   Haynes, William Geoffrey ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Arterial pressure; Obesity; Sympathetic nervous system; Vasoconstriction

Indexed keywords

ISOPRENALINE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENTOLAMINE; PHENYLEPHRINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENERGIC SYSTEM; ADULT; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; HUMAN; MALE; NERVE CONDUCTION; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; VASOCONSTRICTION; VASODILATATION; BRACHIAL ARTERY; COMPARATIVE STUDY; DRUG EFFECT; HOSPITALIZATION; INNERVATION; INTRAARTERIAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BLOOD PRESSURE; BRACHIAL ARTERY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; OBESITY; PHENTOLAMINE; SEVERITY OF ILLNESS INDEX; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; VASODILATION;

EID: 54749109169     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.109603     Document Type: Article

References (57)

1. Cox BD, Whichelow MJ, Ashwell M, Prevost AT, Lejeune SR. Association of anthropometric indices with elevated blood pressure in British adults. Int J Obes (Lond). 1997;21:674-680.
2. Kortelainen ML, Sarkioja T. Coronary atherosclerosis and myocardial hypertrophy in relation to body fat distribution in healthy women: an autopsy study on 33 violent deaths. Int J Obes Relat Metab Disord. 1997;21:43-49.
3. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. BMJ. 1984;289:1257-1261.
4. Engeli S, Sharma AM. Role of adipose tissue for cardiovascular-renal regulation in health and disease. Horm Metab Res. 2000;32:485-499.
5. Julius S, Valentini M, Palatini P. Overweight and hypertension. A 2-way street? Hypertension. 2000;35:807-813.
6. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens. 2001;14:103S-115S.
7. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension. 1991;17:669.
8. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Hypertension/hypertrophy/obesity: body fat and sympathetic nerve activity in healthy subjects. Circulation. 1994;89:2634-2640.
9. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25(part 1):560-563.
10. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M. Interactions between leptin and the human sympathetic nervous system. Hypertension. 2003;41:1072-1079.
11. Wofford MR, Anderson DC Jr, Brown CA, Jones DW, Miller ME, Hall JE. Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens. 2001;14:694-698.
12. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni I. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension. 2007;49:27-33.
13. Jones PP, Snitker S, Skinner JS, Ravussin E. Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. Am J Physiol. 1996;33:E363-E366.
14. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-1872.
15. Grassi G. Seravalle G, Colombo M, Bolla G, Cattaneo BM, Cavagnini F, Mancia GI. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation. 1998;97:2037-2042.
16. Lecheminant JD, Kirk EP, Hall MA, Bailey BW, Jacobsen DJ, Stewart E, Donnelly JE. Impact of different levels of weight loss on blood pressure in overweight and obese women. Dis Manag. 2007;10:83-90.
17. Egan BM, Schork NJ, Weder AB. Regional hemodynamic abnormalities in overweight men. Focus on α-adrenergic vascular responses. Am J Hypertens. 1989;2:428-434.
18. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha-adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987;80:812-817.
19. Vervoort G, Wetzels JF, Lutterman JA, van Doorn LG, Berden JH, Smits P. Elevated skeletal muscle blood flow in noncomplicated type 1 diabetes mellitus: role of nitric oxide and sympathetic tone. Hypertension. 1999;34:1080-1085.
20. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131:485-491.
21. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the Spacelabs 90207 determined by the British Hypertension Society Protocol. J Hypertens. 1991;9:573-574.
22. Haynes WG, Stuchan FE, Webb DJ. Endothelin ETa and ETb receptors mediate vasoconstriction of human resistance and capacitance vessels in vivo. Circulation. 1995;92:357-363.
23. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e) inemia in humans. Circulation. 1999;100:1161-1168.
24. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev. 1979;59:919-957.
25. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: direct evidence from intraneural recordings. Hypertension. 1989;14:177-183.
26. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilatation in normal humans. J Clin Invest. 1991;87:2246-2252.
27. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 1992;19:621-627.
28. Panza JA, Epstein SE, Quyyumi A. Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med. 1991;325:986-890.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
30. Gudbjornsdottir S, Lonnroth P, Sverrisdottir YB, Wallin BG, Elam M. Sympathetic nerve activity and insulin in obese normotensive and hypertensive men [published correction appears in Hypertension. 1996;27:1030]. Hypertension. 1996;27:276-280.
31. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA. The sympathetic nervous system and the metabolic syndrome. J Hypertens. 2007;25:909-920.
32. Morlin C, Wallin BG, Eriksson BM. Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man. Acta Physiol Scand. 1983;119:117-121.
33. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998;98:772-776.
34. Torp KD, Tschakovsky ME, Halliwill JR, Minson CT, Joyner MJ. β-Receptor agonist activity of phenylephrine in the human forearm. J Appl Physiol. 2001;90:1855-1889.
35. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferner C, Westerman R, Jennings G. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol. 1992;453:45-58.
36. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol. 1996;491:881-887.
37. Esler M, Rumantir M, Kaye D, Lambert G. The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? Am J Hypertens. 2001;14(suppl 1):139S-146S.
38. Anderson EA, Wallin BG, Mark AL. Dissociation of sympathetic nerve activity in arm and leg muscle during mental stress. Hypertension. 1987;9(suppl III):III-114-IIi-119.
39. Rea RF, Wallin BG. Sympathetic nerve activity in arm and leg muscles during lower body negative pressure in humans. J Appl Physiol. 1989;66:2778-2781.
40. Neahring JM, Stepniakowski K, Greene AS, Egan BM. insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993;22:584-590.
41. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes. 1999;48:903-908.
42. Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G. Gentile MT, Fratta L, Trimarco V, Trimarco B, Lembo G. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002;51:168-173.
43. Momin AU, Melikian N, Shah AM, Grieve DJ, Wheatcroft SB, John L, El Gamel A, Desai JB, Nelson T, Driver C, Sherwood RA, Kearney MT. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. Eur Heart J. 2006;27:2294-2299.
44. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes. 2005;54:2012-2018.
45. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002;16:1057-1063.
46. Gao YJ, Zeng ZH, Teoh K, Sharma AM, Abouzahr L, Cybulsky I, Lamy A, Semelhago L, Lee RM. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg. 2005;130:1130-1136.
47. Gao YJ, Lu C, Su LY, Sharma AM, Lee RM. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol. 2007;151:323-331.
48. Charkoudian N, Joyner MJ, Sokolnicki LA, Johnson CP, Eisenach JH, Dietz NM, Curry TB, Wallin BG. Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans. J Physiol. 2006;572:821-827.
49. Coppack SW, Horowitz JF, Paramore DS, Cryer PE, Royal HD, Klein S. Whole body, adipose tissue, and forearm norepinephrine kinetics in lean and obese women. Am J Physiol. 1998;275:E830-E834.
50. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96:3423-3429.
51. DiBona GF. Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension. 2000;36:1083-1088.
52. Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E, Lambert G. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension. 2007;50:862-868.
53. Kurpad AV, Kulkarni RN, Vaz M, Shetty PS. Repeated infusions of identical doses of norepinephrine show potentiation of metabolic responses in human subjects. Metabolism. 1989;38:979-982.
54. Van Harmelen V, Lonnqvist F, Thorne A, Wennlund A, Large V, Reynisdottir S, Arner P. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes Relat Metab Disord. 1997;21:972-979.
55. Blaak EE, van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. Total forearm blood flow as an indicator of skeletal muscle blood flow: effect of subcutaneous adipose tissue blood flow. Clin Sci (Lond). 1994;87:559-566.
56. Adams F, Jordan J, Schaller K, Luft FC, Boschmann M. Blood flow in subcutaneous adipose tissue depends on skin-fold thickness. Harm Metab Res. 2005;37:68-73.
57. Minson CT, Halliwill JR, Young TM, Joyner MJ. Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation. 2000;101:862-868.